Role of L-ascorbic acid in the reversal of the monoamine oxidase inhibition by caffeine.
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology*; D002110:Caffeine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004809:Ephedrine / Q000494:pharmacology; D000882:Haplorhini; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D008930:Mitochondria, Liver / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010084:Oxidation-Reduction; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology; D014527:Uric Acid / Q000494:pharmacology
D008996:Monoamine Oxidase Inhibitors; D014527:Uric Acid; D012701:Serotonin; D002110:Caffeine; D007490:Iproniazid; D004809:Ephedrine; D001205:Ascorbic Acid; D014439:Tyramine